Showing 20 of 23 recruiting trials for “diffuse-intrinsic-pontine-glioma”
H3K27M-specific Immune Effector Cells Targeting DMG/DIPG
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
👨⚕️ David S. Ziegler, MD, FRACP, Sydney Children's Hospitals Network📍 20 sites📅 Started Jul 2025View details ↗
CD200AR-L and Allogeneic Tumor Lysate Vaccine Immunotherapy for Recurrent HGG and Newly Diagnosed DMG/DIPG in Children and Young Adults
Safety and Efficacy of Loco-regional B7H3 IL-7Ra CAR T Cell in DIPG
CAR T Cells to Target GD2 for DMG
FUS Etoposide for DMG
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric Diffuse Intrinsic Pontine Gliomas (DIPG)
Oncolytic Virus Ad-TD-nsIL12 for Primary Pediatric Diffuse Intrinsic Pontine Glioma
Oncolytic Virus Ad-TD-nsIL12 for Progressive Pediatric Diffuse Intrinsic Pontine Glioma
Blood Brain Barrier (BBB) Disruption Using Exablate Focused Ultrasound With Doxorubicin for Treatment of Pediatric DIPG
Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0
👨⚕️ Jacques GRILL, MD, PhD, Gustave Roussy, Cancer Campus, Grand Paris📍 50 sites📅 Started Sep 2022View details ↗
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
👨⚕️ David S Ziegler, Pediatric Early Phase Clinical Trial Network📍 34 sites📅 Started Jan 2022View details ↗
rHSC-DIPGVax Plus Checkpoint Blockade for the Treatment of Newly Diagnosed DIPG and DMG
👨⚕️ Ashley Plant-Fox, MD, Ann and Robert H. Lurie Children's Hospital📍 3 sites📅 Started Jan 2022View details ↗
Combination Therapy for the Treatment of Diffuse Midline Gliomas
👨⚕️ Sabine Mueller, MD, PhD, University of California, San Francisco📍 20 sites📅 Started Oct 2021View details ↗
Stereotactic Biopsy Split-Course Radiation Therapy in Diffuse Midline Glioma, SPORT-DMG Study
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
👨⚕️ Sabine Mueller, MD, PhD, University of California, San Francisco📍 6 sites📅 Started Aug 2021View details ↗
GD2 CAR T Cells in Diffuse Intrinsic Pontine Gliomas (DIPG) & Spinal Diffuse Midline Glioma(DMG)
A Study of Low Dose Bevacizumab With Conventional Radiotherapy Alone in Diffuse Intrinsic Pontine Glioma
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →